Applicability of a checklist for clinical screening of the fragile X syndrome

Clinical Genetics

Volumn 52, Issue 4, 1997, Pages 211-215

  Arvio, M ^a,d   Peippo, M ^b   Simola, K O J ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Vaestoliitto   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d NONE   (Finland)

Author keywords

Clinical screening; Fragile X syndrome; Sign checklist

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL EXAMINATION; FINLAND; FRAGILE X SYNDROME; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL DEFICIENCY; NURSE; PREVALENCE; PRIORITY JOURNAL; SCREENING;

EID: 0030728693     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb02549.x     Document Type: Article

References (14)

1. Autio S, Palo J, Aittokallio M, Turunen S. In: Kehitysvammaisuus. Helsinki: WSOY, 1987: 20-31.
2. Butler MG, Mangrum T, Gupta R, Singh DN. A 15-item checklist for screening mentally retarded males for the fragile X syndrome. Clin Genet 1991: 39: 347-354.
3. Butler MG, Singh DN. Clinical and cytogenetic survey of institutionalized mentally retarded patients with emphasis on the fragile X syndrome. JIDR 1993: 37: 131-142.
4. Gabarron J, Lopez I, Glover G, Carbonell P, Fragile X screening program in a Spanish region. Am J Med Genet 1992: 43: 333-338.
5. Hagerman R. Fragile X syndrome. Curr Probl Pediatr 1987: 17: 621-674.
6. Hagerman R, Hull C, Safanda J, Carpenter I, Staley L, O'Connor R, Seydel C, Mazzocco M, Snow K, Thibodeau S, Kuhl D, Nelson D, Caskey T, Taylor A. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 1994: 51: 298-308.
7. Kähkönen M, Alitalo T, Airaksinen E, Matilainen R, Launiala K, Autio S, Leisti J. Prevalence of the fragile X syndrome in four birth cohorts of children of school age. Hum Genet 1987: 77: 85-87.
8. Nolin SL, Snider DA, Jenkins EC, Brown WT, Krawczum M, Stetka D, Houck GJr, Dobkin CS, Strong G, Smith-Dobransky G, Hughes AVK, Kimpton D, Little A, Nagaraja U, Kenefick B, Sullivan C. Fragile X screening in New York State. Am J Med Genet 1991: 38: 251-255.
9. Partington M, Robinson H, Laing S, Turner G. Mortality in the fragile X syndrome: preliminary data. Am J Med Genet 1992: 43: 120-123.
10. Sabaratnam M, Laver S, Butler L, Pembrey M. Fragile X syndrome in North East Essex: towards systematic screening: clinical selection. JIDR 1994: 38: 27-35.
11. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996: 64: 196-197.
12. Turner G, Robinson H, Laing S, van der Berk M, Colley A, Goddard A, Sherman S, Parington M. Population screening for fragile X. Lancet 1992: 339: 1210-1213.
13. Webb T, Bundey S. Prevalence of fragile X syndrome. J Med Genet 1991: 28: 358-360.
14. Webb TP, Thake AI, Bundey SE, Todd J. A cytogenetic survey of a mentally retarded school-age population with special reference to fragile sites. JIDR 1987: 31 (pt 1): 61-71.